ABT vs. IQV: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ABT and IQV, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
ABT dominates in value with a market cap of 231.49 billion USD, eclipsing IQV’s 23.75 billion USD by roughly 9.75×.
IQV carries a higher beta at 1.35, indicating it’s more sensitive to market moves, while ABT remains steadier at 0.74.
| Symbol | ABT | IQV |
|---|---|---|
| Company Name | Abbott Laboratories | IQVIA Holdings Inc. |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Medical - Devices | Medical - Diagnostics & Research |
| CEO | Mr. Robert B. Ford | Mr. Ari Bousbib |
| Price | 133.05 USD | 137.29 USD |
| Market Cap | 231.49 billion USD | 23.75 billion USD |
| Beta | 0.74 | 1.35 |
| Exchange | NYSE | NYSE |
| IPO Date | March 17, 1980 | May 9, 2013 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ABT and IQV over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between ABT and IQV, please refer to the table below.
| Symbol | ABT | IQV |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 17.22 | 18.08 |
| Forward PEG Ratio (TTM) | 1.73 | 1.64 |
| Price-to-Sales Ratio (P/S, TTM) | 5.47 | 1.53 |
| Price-to-Book Ratio (P/B, TTM) | 2.48 | 4.04 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 34.77 | 10.98 |
| EV-to-EBITDA (TTM) | 22.97 | 10.75 |
| EV-to-Sales (TTM) | 5.63 | 2.36 |
| EV-to-Free Cash Flow (TTM) | 35.78 | 16.88 |
Dividend Comparison
ABT delivers a 1.71% dividend yield, blending income with growth, whereas IQV appears to retain its profits, possibly to fund operations, R&D, or other growth initiatives.
| Symbol | ABT | IQV |
|---|---|---|
| Dividend Yield (TTM) | 1.71% | 0.00% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ABT and IQV, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- IQV’s current ratio of 0.82 indicates its assets may not cover near-term debts, whereas ABT at 1.78 maintains healthy liquidity.
| Symbol | ABT | IQV |
|---|---|---|
| Current Ratio (TTM) | 1.78 | 0.82 |
| Quick Ratio (TTM) | 1.27 | 0.82 |
| Debt-to-Equity Ratio (TTM) | 0.14 | 2.43 |
| Debt-to-Assets Ratio (TTM) | 0.16 | 0.53 |
| Interest Coverage Ratio (TTM) | 15.39 | 3.21 |